MYOLEX

Our Myolex® mission is to build the clinical standard to comprehensively assess and display changes in skeletal muscle composition and micro infrastructure to aid in the diagnosis, prognosis, and monitoring of neuromuscular disorders and muscle wasting diseases. We are deeply committed to helping the dedicated clinicians, scientists, caregivers, and above all, patients who are battling these diseases every day... Looking forward, our EIM technology holds great potential to 1) dramatically cut drug clinical trial costs while increasing patient retention, diversity, and in-home muscle measurement; 2) aid in the early disease diagnosis for neuromuscular disorders such as ALS, and 3) even replace far more expensive, non-portable, and often traumatic muscle measurement devices, such as magnetic resonance imaging (MRI), for specific muscle groups and when their clinical imaging advantages are unnecessary... Our driving goal is to assess, monitor, and display changes in skeletal muscle..

Also known as: Myolex Inc.

Primary location: Brookline United States